EFFECT OF ACETYLSALICYLIC ACID, PARACETAMOL AND PLACEBO ON PAIN AND BLOOD LOSS IN DYSMENORRHEIC WOMEN

Torun Janbu, P Løkken, Britt‐Ingjerd Nesheim
In: Acta Obstetricia et Gynecologica Scandinavica · 1979 · vol. 58(S87) , pp. 81–85 · doi:10.3109/00016347909157796 · PMID:380253 · W1977243900
article OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study found no significant difference in pain relief or blood loss between acetylsalicylic acid, paracetamol, and placebo in women with dysmenorrhea.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The analgesic effect of paracetamol, acetyl-salicylic acid, and placebo on dysmenorrhea were compared in a double-blind cross-over study of 30 women. There was a moderate placebo effect, but no significant difference was found between the three treatments. Blood loss was also measured and it did not vary, with the type of drug ingested. It is concluded that paracetamol and acetylsalicylic acid in the doses used (0.5 g x 4 for 3 days) were not effective against heavy dysmenorrhea, and that none of the drugs influenced the amount of blood lost.

My notes (saved in your browser only)

Condition tags

dysmenorrhea

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

Cited by (6)

SciLite annotations

chemicals 7
acetylsalicylic acid paracetamol paracetamol sulfisoxazole acetyl salicylic acid paracetamol acetylsalicylic acid
organisms 2
noordeloos 2009062 noordeloos 2009062

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK